Metabolite results when a drug is metabolized into a modified form which continues to produce effects. Endogenous variables like age, sex, body composition, genetics, and underlying pathologies have an impact on a given body fluid's metabolome. The activity of an enormous variety of enzymes and transporters responsible for the production, transformation, degradation, and compartmentalization of these small molecules typically keeps the levels of the enormous variety of unique small-molecule metabolites tightly regulated. In the brain, endogenous small molecules are typically present at levels that are tightly controlled.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V72414 | Sialyl-Lewis X (sLeX) | 98603-84-0 | Sialyl-Lewis X (sLeX) is a sialyl-acidified polytetrasaccharide and an endogenous antigen. |
![]() |
V84724 | Siastatin B | 54795-58-3 | |
![]() |
V81395 | Simvastatin acid-d6 ammonium (Tenivastatin-d6 (ammonium)) | Simvastatin acid-d6 (ammonium)m is the deuterated form of Simvastatin acid ammonium. | |
![]() |
V81941 | SJ995973 | 2882065-25-8 | SJ995973 is a unique and effective BET protein degrader (PROTAC). |
![]() |
V56228 | Skatole-d3 (3-Methylindole-d3; 3-Methyl-1H-indole-d3) | 111399-60-1 | Skatole-d3 is the deuterium labelled form of Skatole. |
![]() |
V56252 | Skatole-d8 (3-Methylindole-d8; 3-Methyl-1H-indole-d8) | 697807-03-7 | Skatole-d8 is the deuterium labelled form of Skatole. |
![]() |
V71641 | sn-Glycero-3-phosphocholine-d9 (Choline Alfoscerate-d9; Alpha-GPC-d9; L-α-GPC-d9) | 2260669-07-4 | sn-Glycero-3-phosphocholine-d9 is the deuterated form of sn-Glycero-3-phosphocholine. |
![]() |
V82049 | sn-Glycerol 3-phosphate biscyclohexylammonium salt | 29849-82-9 | sn-Glycerol 3-phosphate biscyclohexylammonium salt is produced by the cytosolic glycerol 3-phosphate dehydrogenase pathway, which uses NADH formed during glycolysis to reduce dihydroxyacetone phosphate. |
![]() |
V76500 | sn-Glycerol 3-phosphate lithium | sn-Glycerol 3-phosphate lithium is produced by the cytosolic glycerol 3-phosphate dehydrogenase pathway, which uses NADH formed during glycolysis to reduce dihydroxyacetone phosphate. | |
![]() |
V82170 | Sodium 2-hydroxybutanoate | 5094-24-6 | Sodium 2-hydroxybutanoate is an endogenously produced metabolite. |
![]() |
V72797 | Sodium 2-hydroxybutanoate-d3 | 1219798-97-6 | Sodium 2-hydroxybutanoate-d3 is the deuterium labelled form of Sodium 2-hydroxybutanoate. |
![]() |
V70978 | Sodium 2-oxopropanoate-13C (sodium pyruvate-13C; sodium 2-oxopropanoate-13C) | 124052-04-6 | Sodium 2-oxopropanoate-13C is 13C (carbon 13) labelled Sodium 2-oxopropanoate. |
![]() |
V72445 | Sodium 2-oxopropanoate-13C3 (Sodium pyruvate-13C3) | 142014-11-7 | Sodium 2-oxopropanoate-13C3 is a 13C (carbon 13)-labeled Sodium 2-oxopropanoate. |
![]() |
V72766 | Sodium 2-oxopropanoate-d3 (Sodium pyruvate-d3) | 1316291-18-5 | Sodium 2-oxopropanoate-d3 is the deuterated form of Sodium 2-oxopropanoate. |
![]() |
V72460 | Sodium 3-methyl-2-oxobutanoate | 3715-29-5 | Sodium 3-methyl-2-oxobutanoate is the precursor of pantothenic acid in Escherichia coli. |
![]() |
V71049 | Sodium 3-methyl-2-oxobutanoate-13C,d4 | 1202865-40-4 | Sodium 3-methyl-2-oxobutanoate-13C,d4 is the deuterated form of 13C (carbon 13)-labeled Sodium 3-methyl-2-oxobutanoate. |
![]() |
V92338 | Sodium 3-methyl-2-oxobutanoate-13C,d4-1 | 2483824-45-7 | Sodium 3-methyl-2-oxobutanoate-13C,d4-1 is the deuterated 13C labeled Sodium 3-methyl-2-oxobutanoate. |
![]() |
V81864 | Sodium 3-methyl-2-oxobutanoate-13C4,d3 | 1215605-14-3 | Sodium 3-methyl-2-oxobutanoate-13C4,d3 is the deuterated form of 13C (carbon 13)-labeled Sodium 3-methyl-2-oxobutanoate. |
![]() |
V70939 | Sodium 3-methyl-2-oxobutanoate-13C5 | 1173018-24-0 | Sodium 3-methyl-2-oxobutanoate-13C5 is 13C (carbon 13) labeled Sodium 3-methyl-2-oxobutanoate. |
![]() |
V81420 | Sodium 3-methyl-2-oxobutanoate-d hydrate | Sodium 3-methyl-2-oxobutanoate-d hydrate is the deuterated form of Sodium 3-methyl-2-oxobutanoate. |